Insider Selling: Yaky Yanay Sells 30,150 Shares of Pluristem Therapeutics Stock (PSTI)
Pluristem Therapeutics (NASDAQ:PSTI) CFO Yaky Yanay sold 30,150 shares of the company’s stock in a transaction that occurred on Thursday, January 9th. The shares were sold at an average price of $4.25, for a total transaction of $128,137.50. Following the sale, the chief financial officer now directly owns 1,139,466 shares of the company’s stock, valued at approximately $4,842,731. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Pluristem Therapeutics (NASDAQ:PSTI) remained flat at $4.21 during during mid-day trading trading on Thursday. The stock had a trading volume of 647,590 shares. Pluristem Therapeutics has a 52-week low of $2.47 and a 52-week high of $4.28. The stock has a 50-day moving average of $3.37 and a 200-day moving average of $3.25. The company’s market cap is $252.1 million.
Pluristem Therapeutics Inc (NASDAQ:PSTI) is a bio-therapeutics company engaged in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.